Orion Corporation Welcomes New General Counsel to Leadership Team

Orion Corporation's New Leadership Announcement

Orion Corporation recently announced a significant change in its executive team with the appointment of Mikko Kemppainen as General Counsel. This new role will start on June 1, 2025, following the departure of Olli Huotari, the Senior Vice President responsible for Corporate Functions. Huotari has been an integral part of the Orion team, and his contributions will certainly be missed.

A Transition of Significant Responsibilities

Mikko will assume Huotari's responsibilities, particularly in areas like Compliance, Intellectual Property Rights, Legal Affairs, and Public Affairs. The transition signifies a thoughtful approach by the Orion leadership in ensuring that critical functions continue seamlessly. The remaining responsibilities held by Huotari will be delegated among other talented individuals on the Executive Management Board.

Mikko Kemppainen's Journey With Orion

Mikko Kemppainen, who holds a Master of Laws degree, joined Orion as a Legal Counsel in 2006. His advancement to Head of Legal Affairs in 2007 showcases his dedication and expertise in navigating the legal landscape of the pharmaceutical industry. Before his tenure at Orion, he honed his skills at Hannes Snellman Attorneys Ltd, where he served as an Associate and Senior Associate.

The Words of the President and CEO

Liisa Hurme, President and CEO of Orion Corporation, expressed gratitude for Huotari's invaluable service to the company. She shared her enthusiasm for Kemppainen's appointment, indicating that his extensive background within Orion and the overall pharma industry will greatly benefit the company's growth strategy. The organization is looking forward to Kemppainen's leadership in steering the company toward its objectives.

Reflections on a Distinguished Career

Former Senior Vice President Huotari conveyed his appreciation for the opportunities he has received at Orion. He acknowledged the positive working relationships he had formed and extended his best wishes for the company’s future successes. His remarks underscore the collaborative culture prevalent within Orion, which values strong teamwork.

Orion Corporation: A Legacy of Excellence

With over a century of commitment to pharmaceutical innovation, Orion Corporation continues to thrive by developing, manufacturing, and marketing a diverse range of human and veterinary pharmaceuticals. This transition in leadership comes at a pivotal time as Orion seeks to bolster its position in the pharmaceutical market, focusing heavily on oncology and pain management.

Orion's dedication is evident in their robust portfolio of proprietary and generic medicines as well as their consumer health products. The company's success is reflected in its impressive net sales of EUR 1,190 million in the previous year and a dedicated workforce of around 3,600 employees.

Contact Information

For those interested in further details about this leadership change or the corporate structure at Orion, the primary contact is Liisa Hurme, President and CEO, reachable via telephone. Additionally, Terhi Ormio serves as the Vice President of Communications and can also assist with media inquiries.

Frequently Asked Questions

What is the role of Mikko Kemppainen at Orion Corporation?

Mikko Kemppainen will serve as General Counsel and Secretary to the Board of Directors, effective June 1, 2025.

What responsibilities will Mikko take over?

Mikko will assume responsibilities related to Compliance, Intellectual Property Rights, Legal Affairs, and Public Affairs.

Who is leaving the Orion Corporation?

Olli Huotari, the Senior Vice President, will leave Orion Corporation on May 31, 2025.

What is Orion Corporation known for?

Orion Corporation is a Finnish pharmaceutical company known for developing a variety of human and veterinary pharmaceuticals, focusing on oncology and pain management.

What are Orion Corporation's recent financial highlights?

Orion reported net sales of EUR 1,190 million in the previous year, with a workforce of approximately 3,600 employees.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.